Aspire Biopharma Holdings, Inc.

Aspire Biopharma Holdings, Inc., trading under the ticker PWUP, is a special purpose acquisition company focused on the biopharmaceutical and life sciences sector. The company filed an 8-K with the Securities and Exchange Commission on December 26, 2024, under accession number 0001493152-24-052097, indicating a material corporate development during the period. SPACs operating in the biopharma space seek to identify and consummate business combinations with private life sciences companies pursuing public market access, and PWUP represents an active vehicle within that segment. The December 2024 filing adds to the company's public disclosure record as it continues to navigate its SPAC lifecycle. Sign up on SpacDesk for full filing history, sponsor data, and deal-stage analytics on PWUP and the broader SPAC market.